Diabetic Foot Ulcers: Clinical Trials

103 trials for Diabetic Foot Ulcers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

56 completed, 22 unknown, 14 terminated, 6 withdrawn. 43 Not applicable, 17 Phase 2, 14 Phase 4, 13 Phase 3, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable43Completed 25, Terminated 8, Unknown 7, Withdrawn 3
Phase 217Completed 8, Unknown 4, Active not recruiting 2, Terminated 2, Withdrawn 1
Phase 414Completed 9, Unknown 3, Terminated 1, Withdrawn 1
Phase 313Completed 7, Terminated 3, Unknown 3
Phase 112Completed 5, Unknown 3, Terminated 2, Active not recruiting 1, Withdrawn 1
Early Phase 12Not yet recruiting 1, Unknown 1

Follow Diabetic Foot Ulcers: new trials by email Literature Review of Diabetic Foot Ulcers trials Research Report on Diabetic Foot Ulcers

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Non Vascular Risk Factors for Severity of Diabetic Foot Ulcers (DFUs)
Diabetic Foot Ulcers, Diabetes Mellitus
Not yet recruitingAssiut University1002025-12-012025-09-26
Wound Dressing Patch with Kelulut Honey-Infused Alginate (Tri-Gnate Alginate) for Effective Wound Care Management
Tri-Gnate Alginate Dressing, Dressing product from Manuka honey, Bactigras + Dermacyn - Diabetic Foot Ulcers
Early Phase 1Not yet recruitingMohd Khairul Zul Hasymi Firdaus1102025-11-012025-03-13
Dressing Method (Self-dressing vs. Nurse-led Dressing) on Healing Outcomes in Diabetic Foot Ulcers
Self-dressing, Nurse-led dressing - Dressing, Self-dressing
Not applicableCompletedAin Shams University602025-10-012026-05-22
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Antimicrobial Peptide PL-5 Topical Spray and Placebo - Diabetic Foot Ulcers
Phase 2Active not recruitingJiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.902024-01-302025-05-25
The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer
Methylene Blue, Milk (control), Methylene Blue and Platelet-Rich Plasma-Fibrin Glue - Diabetic Foot Ulcers, Diabetic Wound
Early Phase 1UnknownMashhad University of Medical Sciences202023-04-302023-10-04
Topical Insulin Dressing on Management of Diabetic Foot Ulcers
Insulin, Normal saline - Topical, Insulin
Not applicableCompletedCairo University302023-01-012026-02-25
Registry HBOT in DFU
HBOT - Diabetic Foot Ulcers
RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)6002022-11-012024-11-18
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant - Diabetic Foot Ulcers
Phase 1CompletedOmeza, LLC252022-09-012024-06-21
Effectiveness of Buerger Allen Exercise Among Type 2 Diabetes Mellitus Patients With Foot Ulcer
Buerger Allen Exercises - Diabetic Foot Ulcers
Not applicableCompletedGazi University722022-03-102023-02-28
A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.
ON101 Cream, Placebo - Diabetic Foot Ulcers
Not applicableCompletedOneness Biotech Co., Ltd.132021-02-232023-01-05
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers
PRP Concepts Fibrin Bio-Matrix, Usual and Customary Practice - Diabetic Foot Ulcers
Not applicableUnknownPRP Concepts, LLC2002021-01-012021-04-13
Topical Oxygen Therapy for Diabetic Wounds
Topical Oxygen Chamber for Extremities - Diabetic Foot Ulcers, Wound
Not applicableTerminatedIndiana University42020-02-012024-04-25
The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers
PRP-Fibrin Glue, Vitamin E and C, Placebo - Diabetic Foot Ulcers, Diabetic Wound
Phase 2 / Phase 3UnknownMashhad University of Medical Sciences242019-08-282020-03-20
Wound Healing Endpoint and Recurrence
Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound
Phase 1 / Phase 2Active not recruitingSashwati Roy1002019-01-082025-09-26
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Granexin gel, Vehicle gel - Diabetic Foot Ulcers
Phase 3TerminatedXequel Bio, Inc.1242018-11-212020-05-29
Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer
Autologous platelet rich plasma gel, Placebo - Diabetic Foot Ulcers
Not applicableUnknownRegen Lab SA1922018-04-122020-10-08
Omnigen DFU Pilot Study
Omnigen, Dummy Packaging - Diabetic Foot Ulcers
Not applicableCompletedUniversity Hospitals of Derby and Burton NHS Foundation Trust312018-03-112020-01-09
Evaluation of ABSOLVE in Diabetic Foot Ulcers
RhPDGF-BB, Placebo - Diabetic Foot Ulcers
Phase 2UnknownLynch Biologics LLC402017-01-302017-01-31
Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers
Affinity Allograft, Standard of care - Diabetic Foot Ulcers
Not applicableCompletedOrganogenesis892016-08-012020-02-19
Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers
EpiCord, Standard of Care - Diabetic Foot Ulcers
Not applicableCompletedMiMedx Group, Inc.1302016-07-012022-05-13

Showing 20 of 103. Sign in to see all of them.

Narrower conditions

Diabetic Foot (103)  ·  Diabetes Mellitus (21)  ·  Wounds and Injuries (14)  ·  Foot Ulcer (11)  ·  Ulcer (11)  ·  Pressure Ulcer (8)  ·  Varicose Ulcer (5)  ·  Foot Diseases (4)  ·  Burns (3)  ·  Diabetes Complications (3)  ·  Osteomyelitis (3)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Diabetic Neuropathies (2)  ·  Leg Ulcer (2)  ·  Surgical Wound Dehiscence (2)

Broader conditions

Skin and Connective Tissue Diseases (103)  ·  Cardiovascular Diseases (102)  ·  Diabetic Angiopathies (102)  ·  Endocrine System Diseases (102)  ·  Skin Diseases (102)  ·  Skin Ulcer (102)  ·  Vascular Diseases (102)  ·  Diabetic Neuropathies (101)  ·  Leg Ulcer (101)  ·  Diabetes Complications (100)  ·  Foot Ulcer (92)  ·  Diabetes Mellitus (82)  ·  Nutritional and Metabolic Diseases (24)  ·  Glucose Metabolism Disorders (23)  ·  Metabolic Diseases (23)

Interventions

Standard of Care (11)  ·  Collagenases (4)  ·  Becaplermin (3)  ·  Hydrogels (3)  ·  Ciprofloxacin (2)  ·  Debridement (2)  ·  Maggot Debridement Therapy (2)  ·  Ofloxacin (2)  ·  Saline Solution (2)  ·  aclerastide (2)  ·  pexiganan (2)  ·  Acetylcysteine (1)  ·  Alloderm (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Apligraf (1)

Sponsors

Healthpoint (7)  ·  Integra LifeSciences Corporation (3)  ·  KCI USA, Inc (3)  ·  MiMedx Group, Inc. (3)  ·  US Department of Veterans Affairs (3)  ·  University of Texas Southwestern Medical Center (3)  ·  Abeona Therapeutics, Inc (2)  ·  Assaf-Harofeh Medical Center (2)  ·  Cytomedix (2)  ·  Mashhad University of Medical Sciences (2)  ·  Molnlycke Health Care AB (2)  ·  Osiris Therapeutics (2)  ·  SANUWAVE, Inc. (2)  ·  Skingenix, Inc. (2)  ·  U.S. Wound Registry (2)

Countries

United States (67)  ·  Canada (10)  ·  United Kingdom (6)  ·  Sweden (4)  ·  Denmark (3)  ·  Germany (3)  ·  India (3)  ·  Iran (3)  ·  Spain (3)  ·  Egypt (2)  ·  Israel (2)  ·  Italy (2)  ·  China (1)  ·  Guatemala (1)  ·  Hungary (1)

Top investigators

Herbert B Slade, MD (5)  ·  Daryoush Hamidi Alamdari, Ph.D (2)  ·  John Fryer, Ph.D. Asst. Director (2)  ·  Lawrence Lavery, DPM (2)  ·  Paul Litka, MD (2)  ·  Robert S Kirsner, MD, PhD (2)  ·  Wijegupta Ellepola, Program Analyst (2)  ·  Aksone Nouvong, D.P.M. (1)  ·  Aksone Nouvong, DPM (1)  ·  Alan Dunton, MD (1)  ·  Albert Rabinovitz, MD (1)  ·  Alireza Goodarzi, MSc (1)  ·  Alisha Oropallo, MD (1)  ·  Anders Nilsson, MD (1)  ·  Andreas Nikolis, Dr (1)

Results publications

PMID 18990064, PMID 18601587, PMID 19064169, PMID 19128245, PMID 19152653, PMID 19170984, PMID 19424751, PMID 19641161, PMID 20873963, PMID 23736928, PMID 2403699, PMID 24130347, PMID 24145042, PMID 25767565, PMID 25790480, PMID 26978860, PMID 32139102, PMID 33646060, PMID 34398099, PMID 3753059

NIH funding

R42DK069871 (1), R44AR046154 (1)